Obesity Action Coalition (OAC) Applauds Biden Administration's Efforts to Increase Access to Obesity Care

PR Newswire

TAMPA, Fla., Aug. 29, 2024

TAMPA, Fla., Aug. 29, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) commends the Biden Administration for raising awareness of the need to expand access to obesity care and reduce the high cost of obesity medications. President Biden's recent announcement marks a significant step forward in a national effort to enhance care and support for individuals affected by obesity.

Obesity is a complex and chronic disease that impacts more than 100 million Americans, requiring comprehensive, long-term management. However, high medication costs and limited insurance coverage often prevent individuals from receiving necessary treatments. The OAC is encouraged by the Administration's commitment to making these essential treatments more affordable and accessible to all.

"This is a substantial move forward in the national conversation about obesity and its treatment," said Joe Nadglowski, OAC President and CEO. "It reinforces the critical need for affordable, evidence-based treatments for obesity, similar to those available for other chronic diseases."

The OAC urges the public to support our efforts to increase access to obesity care and make these treatments more affordable. Take action today by signing our national petition to advocate for access and affordability changes in obesity care policies. Additionally, the OAC remains committed to advocating for fair drug pricing policies to ensure all individuals have access to the care they need. For more information on the OAC's stance on drug pricing for obesity medications, please visit our website.

About:

The Obesity Action Coalition (OAC), a more than 85,000 member-strong National nonprofit organization dedicated to improving the lives of individuals affected by the disease of obesity through education, advocacy and support. The OAC is the first and only organization of its kind and the nation's leading voice representing those impacted by obesity. To learn more about our work, please visit www.ObesityAction.org.

View original content:https://www.prnewswire.com/news-releases/obesity-action-coalition-oac-applauds-biden-administrations-efforts-to-increase-access-to-obesity-care-302234192.html

SOURCE Obesity Action Coalition

Latest Press Release on Obesity News

Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity

PR Newswire HONG KONG, Sept. 17, 2024 - ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally...

Obesity Action Coalition (OAC) Responds to New CDC Obesity Maps, Calls for Expanded Access to Care

PR Newswire TAMPA, Fla., Sept. 12, 2024 TAMPA, Fla., Sept. 12, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) today responded to the Centers for Disease Control and Preventi...

AI-Driven Femtech Devices Market to Grow by USD 8.6 Billion (2024-2028) as Infertility and Obesity Rates Rise - Technavio Report

PR Newswire NEW YORK, Sept. 12, 2024 NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global femtech devices market size is estimated to grow...

New Report: U.S. Rates of Obesity Among Adults at Epidemic Levels

PR Newswire WASHINGTON, Sept. 12, 2024 Obesity Rates are Predominantly Highest in Communities Experiencing Barriers to Healthy Eating and Those with Few Opportunities for Physical Ac...

Apnimed to Present New Findings on the Prevalence of Obesity Hypoventilation Syndrome (OHS) at the European Respiratory Society (ERS) Congress 2024

PR Newswire CAMBRIDGE, Mass., Sept. 4, 2024 CAMBRIDGE, Mass., Sept. 4, 2024 /PRNewswire/ -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on discovery, development a...